Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maschmeyer

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Hematology/Oncology Clinics of North America|January 9, 2001
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)N Gökbuget, D Hoelzer, R Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)M Ruhnke, A Böhme, D Buchheidt, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year periodG Maschmeyer, F-L Bertschat, K T Moesta, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2019
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)K Klinghammer, T Gauler, A Dietz, et al.
Annals of Hematology|September 1, 2017
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)W J Heinz, D Buchheidt, M Christopeit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II studyT Kiefer, C Hirt, C Späth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)A Thiel, J Schetelig, W Pönisch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 20, 2002
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigatorsT Büchner, W Fegeler, H Bernhardt, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|January 9, 2001
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)N Gökbuget, D Hoelzer, R Arnold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)M Ruhnke, A Böhme, D Buchheidt, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year periodG Maschmeyer, F-L Bertschat, K T Moesta, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2019
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)K Klinghammer, T Gauler, A Dietz, et al.
Annals of Hematology|September 1, 2017
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)W J Heinz, D Buchheidt, M Christopeit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II studyT Kiefer, C Hirt, C Späth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)A Thiel, J Schetelig, W Pönisch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 20, 2002
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigatorsT Büchner, W Fegeler, H Bernhardt, et al.
Pageof 9